Safari Flower Company, a wholly owned subsidiary of Aurora Cannabis Inc. (NASDAQ: ACB), has received European Union Good Manufacturing Practice (EU-GMP) certification for its facility in the Niagara Region of Ontario, Canada, according to a company statement.

The certification, valid for a three-year term, covers Safari's 59,000 square foot cultivation and manufacturing site. The certification is intended to support the company's exports of medical cannabis to international markets including Germany, Poland, and the United Kingdom.

"We are incredibly proud to achieve the highest level of EU-GMP certification, which reinforces our position as a trusted cultivator and manufacturer of high-quality medical cannabis for international markets," said Brigitte Simons, CEO of Safari Flower Company.

Aurora acquired Safari Flower Company in April 2026 to add EU-GMP certified capacity to its global manufacturing network. The Niagara facility has a prior history of EU-GMP accreditation and export operations.